PROTECT: prospective phase-II-trial evaluating adaptive proton therapy for cervical cancer to reduce the impact on morbidity and the immune system

Author(s):: Corbeau, A. (0000-0003-3919-5135); Nout, R.A.; Mens, J.W.M.; Horeweg, N. (0000-0002-8581-4753); Godart, J.; Kerkhof, E.M.; Kuipers, S.C.; Poelgeest, M.I.E. van; Kroep, J.R. (0000-0003-2671-1903); Boere, I.A.; Doorn, H.C. van; Hoogeman, M.S.; Heide, U.A. van der; Putter, H. (0000-0001-5395-1422); Welters, M.J.P.; Burg, S.H. van der (0000-0002-6556-0354); Creutzberg, C.L. (0000-0002-7008-4321); Boer, S.M. de (0000-0002-8454-1597)

Published: 2021
Publication type: Article / Letter to editor

Date issued: 2021-10-15
Language: English
Publisher: MDPI
Is part of: Cancers (2021), No. 20
hdl: 1887/3277436
doi: 10.3390/cancers13205179
URL: https://www.mdpi.com/2072-6694/13/20/5179/pdf